Novel Agents in CML Therapy:The Tyrosine Kinase Inhibitors and Beyond

See this article Novel Agents In CML Therapy: Tyrosine Kinase Inhibitors and Beyond

See also these links:

                              Bosutinib

                                   Bafetinib

                                        Danusertib

                                             Ponatinib

                                                 Rebastinib

                                                      Omacetaxine

                                                         Radotinib